Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1Dermatologic 1

Conditions

Keratosis, Actinic 5Lymphoma, T-Cell, Cutaneous 2Mycosis Fungoides 1Keratosis 1Dermatitis, Contact 1

Interventions

Peripheral Blood Stem Cell Transplantation 38fludarabine phosphate 34Cyclophosphamide 30Mycophenolic Acid 25Whole-Body Irradiation 22Cyclosporine 22Tacrolimus 21Busulfan 18Methotrexate 17Antilymphocyte Serum 16Radiotherapy 14Flow Cytometry 13Filgrastim 13Etoposide 13Vorinostat 10Methylprednisolone 10Bortezomib 10Bexarotene 10Melphalan 9Therapeutics 8Rituximab 8Psychiatric Rehabilitation 8Polymerase Chain Reaction 8Lenalidomide 8Gemcitabine 8romidepsin 7fludarabine 6Cord Blood Stem Cell Transplantation 6Brentuximab Vedotin 6tanespimycin 5

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Mycosis Fungoides × Ointments × Dermatologic × Clear all
NCT03380026 2021-11-24

MIDAS

Rochester Skin Lymphoma Medical Group, PLLC

Phase 2 Completed
28 enrolled 8 charts
DermatologicLymphoid

Dermatitis, Contact, Mycosis Fungoides, Lymphoma, T-Cell, Cutaneous

Data powered by HemOnc (CC BY 4.0) Colophon âš¡